Menu Back toAssessment Methods and Analytics to Ensure Data Capture from Heterogeneous Populations
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Assessment Methods and Analytics to Ensure Data Capture from Heterogeneous Populations
Sonya Eremenco, MA
- Executive Director, PRO Consortium
- Critical Path Institute, United States
This session will present an overview of the challenges with assessment methods and analytics in heterogeneous populations with case studies focusing on dermatology assessments in people of color and on methods to address heterogeneity in rare disease populations.
Learning Objective : Describe the challenges associated with using single primary clinical trial endpoints for rare and ultra-rare diseases; Explain the multi-domain responder index analysis approach and summarize the benefits of this approach compared with traditional clinical trial design.
The Importance of Accounting for Diversity When Training Clinicians to Apply Dermatological Rating Scales in Clinical Trials
Alexandra Kalpadakis, PhD, MSc
- Scientific Advisor
- Signant Health, United Kingdom
Multi-Domain Responder Index: A Novel Analysis Tool to Capture Broad Clinical Benefit in Heterogeneous Complex Rare Diseases
P. K. Tandon, PhD
- Senior Vice President, Biometrics and Development Strategy
- Ultragenyx Pharmaceutical, United States